Androgen-Dependent transcriptional regulation of the prostate-specific antigen gene by thyroid hormone 3,5,3'-L-triiodothyronine

J Androl. 2001 Jan-Feb;22(1):136-41.

Abstract

Prostate-specific antigen (PSA) is the most useful biomarker for human prostate cancer and may play a role in prostate tumor biology. Androgens, via their receptors, are the major positive regulators of PSA expression. Recently, we showed that thyroid hormone 3,5,3'-L-triiodothyronine (T3) also increases androgen-dependent PSA expression, even though androgen receptor expression is not affected. This report demonstrates for the first time that there is a functional T3-responsive element (TRE) in the 5'-promoter region of the PSA gene. Mutation of this TRE reduced the T3-enhanced androgenic activation of the PSA promoter. Our study provides direct evidence that the PSA gene is regulated by T3 at the transcriptional level.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Androgens / metabolism*
  • Blotting, Northern
  • Blotting, Western
  • Gene Expression / drug effects
  • Humans
  • Male
  • Promoter Regions, Genetic
  • Prostate-Specific Antigen / analysis
  • Prostate-Specific Antigen / genetics*
  • Prostatic Neoplasms
  • RNA, Messenger / analysis
  • Transcriptional Activation / drug effects*
  • Transcriptional Activation / physiology*
  • Transfection
  • Triiodothyronine / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Androgens
  • RNA, Messenger
  • Triiodothyronine
  • Prostate-Specific Antigen